Periodic Reporting for period 1 - ADHERE (Aptamer nanostructures dual-targeted to the HER receptor family for cancer therapy)

In cancer immunotherapy, antibodies that target specific antigens expressed by cancer cells are used as therapeutic agents. Among these, antibodies directed to HER1, better known as EGFR, and HER2 have shown a favorable outcome in the clinical management of several types of...